MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517029037 A) filed by Mirati Therapeutics, Inc., Princeton, U.S.A., on March 27, for 'combination therapies using prmt5 inhibitors and bcl-2 family inhibitors for the treatment of cancer.'
Inventor(s) include Engstrom, Lars, Daniel; Olson, Peter; Waters, Laura; and Bowcut, Vickie.
The application for the patent was published on April 18, under issue no. 16/2025.
According to the abstract released by the Intellectual Property India: "Disclosed herein are methods of treating cancer. More specifically, this disclosure provides methods for treating cancer in a subject using compounds that are inhibitors of PRMT5, particularly in combination with a B...